For professional use only

Advanced Pharmaceutical Distribution & Innovation

Strategic partner for pharmaceutical companies and global distributors

Lanzes Genetics is an international pharmaceutical distribution company focused on delivering next-generation therapies across regulated markets. We collaborate with laboratories and healthcare partners worldwide, ensuring compliant, efficient and scalable access to innovative treatments.

As part of an international group with strong presence across multiple sectors, Lanzes Genetics operates at the intersection of innovation, compliance and global distribution.

We specialize in sourcing, regulatory coordination and international commercialization of advanced pharmaceutical products, with a particular focus on metabolic and therapeutic innovations.

Regulatory Expertise

We work with products aligned with FDA standards and ongoing EMA authorization processes

Global Reach

Active presence in Europe, Latin America, Africa and Middle East

Strategic Distribution

Tailored solutions for pharmaceutical companies, wholesalers and institutional buyers

ABOUT US

About Lanzes Genetics

Lanzes Genetics is a pharmaceutical distribution company specialized in international markets, operating under the structure of a global group with diversified activity in healthcare and strategic industries.

Our mission is to facilitate access to innovative pharmaceutical solutions by connecting manufacturers, regulatory frameworks and distribution channels worldwide.

We combine technical expertise, regulatory knowledge and operational capacity to ensure safe and efficient product deployment across multiple jurisdictions.

.

PHARMACEUTICAL SOLUTIONS

Integrated Pharmaceutical Solutions

We provide end-to-end pharmaceutical solutions tailored to the needs of laboratories, distributors and healthcare organizations.

SERVICES

PRODUCTS PORTFOLIO

Innovative Therapeutic Portfolio

Our portfolio includes advanced pharmaceutical solutions designed to address current global health challenges, particularly in metabolic and chronic disease management.

A next-generation therapeutic solution combining semaglutide and niacinamide, designed to support metabolic regulation and weight management under medical supervision.

Available in injectable and oral formats, with flexible treatment protocols.

Advanced dual-action therapy based on tirzepatide and niacinamide, targeting metabolic pathways for enhanced efficacy in weight control and glycemic balance.

Developed in line with international pharmaceutical standards.

REGULATORY & COMPLIANCE

Regulatory Excellence

Lanzes Genetics operates under strict compliance with international pharmaceutical regulations, ensuring that all products meet the highest standards of safety, quality and efficacy.

Our portfolio includes products aligned with FDA requirements and in process of authorization before the European Medicines Agency (EMA).

We support our partners in navigating complex regulatory environments, facilitating smooth market entry and commercialization.

GLOBAL DISTRIBUTION

Global Distribution Network

We manage international pharmaceutical distribution across key markets, leveraging a robust network of partners and logistics capabilities.

Partnerships

Strategic Partnerships

We collaborate with pharmaceutical manufacturers, research laboratories and distribution companies seeking reliable international expansion.

If you are looking to expand your pharmaceutical products into new markets, Lanzes Genetics offers the expertise and infrastructure to support your growth.